Cancer Research UK on The Rest Is Science

This episode is brought to you by Cancer Research UK. We often think of beating cancer as treatment, but imagine stopping it before it begins. After years of work, cancer research UK scientists are launching a clinical trial of lung vax, the first vaccine designed to prevent lung cancer. It builds on TRACERx, the world's largest cancer evolution study, which tracked lung cancer cells over many years to uncover the disease's earliest warning signs. Lungvax is designed to train the immune system to spot these signs early on, destroying faulty cells before cancer develops. So it's not treatment, but preventative with the potential to stop lung cancer before it starts. The first stage of the trial starts this year focusing on people at higher risk. It shows what long term research makes possible. For more information about Cancer Research UK, their research breakthroughs, and how you can support them, visit cancerresearchuk.org forward slash therestisscience.